Literature DB >> 2710353

The Canadian Neurological Scale: validation and reliability assessment.

R Côté1, R N Battista, C Wolfson, J Boucher, J Adam, V Hachinski.   

Abstract

The Canadian Neurological Scale (CNS) was designed to monitor mentation and motor functions in stroke patients. We assessed its validity and reliability on a group of 157 patients with a diagnosis of acute cerebrovascular accident. We determined validity by (1) correlating scale items and total score with the standard neurologic examination; (2) exploring the scale's predictive power with different end points at 6 months--the initial CNS was a significant predictor of outcome; (3) showing that the CNS had higher correlation coefficients with the initial neurologic examination than the Glasgow Coma Scale; and (4) assessing the responsiveness of the scale to change in the neurologic status of stroke patients. Interobserver reliability, measured by kappa statistics on each scale item, was good. Accordingly, we established the validity and reliability of the CNS for its use in clinical studies and in the care of stroke patients.

Entities:  

Mesh:

Year:  1989        PMID: 2710353     DOI: 10.1212/wnl.39.5.638

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  62 in total

Review 1.  A review of health-related quality-of-life measures in stroke.

Authors:  B A Golomb; B G Vickrey; R D Hays
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

Review 2.  Outcomes of neurocritical care.

Authors:  G Y Sung
Journal:  Curr Neurol Neurosci Rep       Date:  2001-11       Impact factor: 5.081

3.  Post-stroke rehabilitation: an economic or medical priority? Current issues and prospects in light of new legislative regulations.

Authors:  S Paolucci; M Traballesi; L Emberti Gialloreti; L Pratesi; S Lubich; A Salvia; M G Grasso; D Morelli; M Pulcini; E Troisi; P Coiro; C Caltagirone
Journal:  Ital J Neurol Sci       Date:  1998-02

4.  Effectiveness of virtual reality using Wii gaming technology in stroke rehabilitation: a pilot randomized clinical trial and proof of principle.

Authors:  Gustavo Saposnik; Robert Teasell; Muhammad Mamdani; Judith Hall; William McIlroy; Donna Cheung; Kevin E Thorpe; Leonardo G Cohen; Mark Bayley
Journal:  Stroke       Date:  2010-05-27       Impact factor: 7.914

5.  Change in quality of life of people with stroke over time: true change or response shift?

Authors:  Sara Ahmed; Nancy E Mayo; Marc Corbiere; Sharon Wood-Dauphinee; James Hanley; Robin Cohen
Journal:  Qual Life Res       Date:  2005-04       Impact factor: 4.147

6.  Obstructive Sleep Apnea is Related to Impaired Cognitive and Functional Status after Stroke.

Authors:  Justine A Aaronson; Coen A M van Bennekom; Winni F Hofman; Tijs van Bezeij; Joost G van den Aardweg; Erny Groet; Wytske A Kylstra; Ben Schmand
Journal:  Sleep       Date:  2015-09-01       Impact factor: 5.849

7.  Is pre-existing dementia an independent predictor of outcome after stroke? A propensity score-matched analysis.

Authors:  Gustavo Saposnik; Moira K Kapral; Robert Cote; Paula A Rochon; Julie Wang; Stavroula Raptis; Muhammad Mamdani; Sandra E Black
Journal:  J Neurol       Date:  2012-04-25       Impact factor: 4.849

8.  Neighborhood income and stroke care and outcomes.

Authors:  Moira K Kapral; Jiming Fang; Crystal Chan; David A Alter; Susan E Bronskill; Michael D Hill; Douglas G Manuel; Jack V Tu; Geoffrey M Anderson
Journal:  Neurology       Date:  2012-08-15       Impact factor: 9.910

9.  Application of technetium-99m hexamethylpropylene amine oxime single-photon emission tomography to neurologic prognosis in patients undergoing urgent carotid surgery.

Authors:  I Y Shvera; A M Cherniavsky; W Y Ussov; M P Plotnikov; A A Sokolov; V M Shipulin; V I Chernov
Journal:  Eur J Nucl Med       Date:  1995-02

10.  Identifying response shift statistically at the individual level.

Authors:  Nancy E Mayo; Susan C Scott; Nandini Dendukuri; Sara Ahmed; Sharon Wood-Dauphinee
Journal:  Qual Life Res       Date:  2008-05       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.